QuantuMDx
PrivateLast Round
VC Round
Nov 8, 2021
Total Funding Raised
$16.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
QuantuMDx is a British medical technology company founded in 2008 that specializes in developing molecular diagnostic solutions for point-of-care testing. The company's mission is to make high-quality, rapid diagnostics accessible and affordable globally, particularly in resource-limited settings. Its flagship product, the Q-POC™, is a portable, battery-operated PCR system that provides rapid, actionable results in approximately 30-35 minutes. QuantuMDx is a privately held, venture-backed company that has progressed to a Series D funding stage. The company is headquartered in Newcastle upon Tyne, UK, and has global partnerships across multiple continents.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QuantuMDx Comparables
Compare QuantuMDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Credo Diagnostics Biomedical | 87% | |
| Nuclein | 86% | |
| binx health | 81% | |
QuantuMDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 8, 2021 | ||||
| Debt | Mar 24, 2021 | ||||
| Grant | Oct 17, 2013 |
Key People
Founding team and executive leadership
QuantuMDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| British Business Bank | Debt |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 139% MoM.
QuantuMDx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |